Cytosorbents Crp (CTSO) — Cash Flow Reinvestment Rate
Latest as of June 2020:
0.51x
Cytosorbents Crp (CTSO) has a Cash Flow Reinvestment Rate of 0.51x as of June 2020, reinvesting $994.72K (capex $497.36K plus investments $-497.36K) from operating cash flow of $1.94 Million. Explore reinvestment intensity of Cytosorbents Crp to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
0.51x
(Capex + Investments) / Operating CF
Total Reinvested
$994.72K
Capex + Investments
Operating Cash Flow
$1.94 Million
USD
Capital Expenditures
$497.36K
USD
Annual Cash Flow Reinvestment Rate for Cytosorbents Crp (None–None)
Year-by-year capital reinvestment analysis for Cytosorbents Crp. For live market cap and broader valuation context, see Cytosorbents Crp (CTSO) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow